Lv1
44 积分 2025-09-28 加入
A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial
12天前
已完结
Effectiveness and safety of finerenone in IgA nephropathy patients
18天前
已完结
Efficacy and safety of belimumab in IgA nephropathy: real-world evidence
23天前
已完结
Effectiveness and safety of finerenone in IgA nephropathy patients
28天前
已完结
Hydroxychloroquine use in pediatric IgA nephropathy
1个月前
已完结
When “Low-Grade” Is No Longer Low Risk in IgA Nephropathy
1个月前
已完结
Efficacy and safety of supportive and immunosuppressive therapies in the treatment of lgA nephropathy: a network Meta-analysis of randomized clinical trials
1个月前
已完结
The immunohistology of IgA nephropathy
1个月前
已完结
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
2个月前
已完结
Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
2个月前
已完结
皖公网安备34019202002308
